SKI-1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SKI-1 monoclonal antibodies for research focused on understanding SKI-1's role in various biological processes. SKI-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SKI-1, also known as SREBP cleavage-activating protein, plays a crucial role in lipid metabolism and cellular homeostasis by regulating the processing of sterol regulatory element-binding proteins (SREBPs). SKI-1 is essential for the synthesis of cholesterol and fatty acids, making it a significant factor in metabolic disorders and cardiovascular diseases. Research focused on SKI-1 can reveal potential therapeutic targets for these conditions. Scientists worldwide use SKI-1 monoclonal antibodies to advance their understanding of lipid metabolism pathways. Ongoing studies of SKI-1 continue to uncover new insights into its biological functions and disease associations. Research utilizing SKI-1 monoclonal antibodies contributes to expanding knowledge in cellular metabolism and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful discoveries that advance scientific understanding of human health and disease.